Back to Search
JOSEPH CONTESSA, M.D., PH.D.
M.D., PH.D.
Radiation Oncology Physician
NPI: 1639298318IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
25MA12833800(NJ)047485(CT)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
4301083650(MI)
Specialist
Specialist
Code: 174400000X
4301083650(MI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2004
Research & Publications (15)
Radiotherapy for pancreatic neuroendocrine tumors.
PMID 19327905·Int J Radiat Oncol Biol Phys·2009
8-other
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells.
PMID 18483264·Cancer Res·2008
8-other
Revoking the privilege: targeting HER2 in the central nervous system.
PMID 17981994·Mol Pharmacol·2008
6-review
Using ErbB2-negative status to direct therapy in locally advanced breast cancer.
PMID 17471028·Cancer Biol Ther·2007
8-other
ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
PMID 16751066·Int J Radiat Oncol Biol Phys·2006
8-other
Targeted radiation for melanoma: alpha therapy prepares for a beta test.
PMID 16491043·Cancer Biol Ther·2006
8-other
Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
PMID 16267617·Breast Cancer Res Treat·2006
8-other
Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours.
PMID 14530165·Int J Radiat Biol·2003
8-other
EGFRvIII-mediated radioresistance through a strong cytoprotective response.
PMID 12944901·Oncogene·2003
7-preclinical
Stress and radiation-induced activation of multiple intracellular signaling pathways.
PMID 12600231·Radiat Res·2003
6-review
Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells.
PMID 12037685·Oncogene·2002
8-other
Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
PMID 11697324·Int J Radiat Oncol Biol Phys·2001
8-other
Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization.
PMID 11416113·J Natl Cancer Inst·2001
7-preclinical
Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
PMID 11297265·Clin Cancer Res·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 CEDAR ST, HUNTER RADIATION THERAPY CENTER
NEW HAVEN, CT 06510 - Phone
- (203) 688-4344
Quick Facts
- NPI
- 1639298318
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 22
- Publications
- 15
Are you this provider?
Claim Your Profile